Betaine (TMG)
Methyl donor that lowers homocysteine and may aid lower-body strength.
What is Betaine (TMG)?
Betaine (TMG) (Trimethylglycine) is a performance supplement used for lower plasma homocysteine. NutriDex grades the human evidence as Moderate. Betaine (trimethylglycine, TMG) is a methyl donor found in beets and whole grains. Its best-replicated effect is lowering plasma homocysteine: a meta-analysis of 5 RCTs found 4-6 g/day cut it by about 1.23 micromol/L (~12%). Whether this translates to fewer heart events is unproven, and the same and later meta-analyses show betaine moderately raises total and LDL cholesterol (~14 and ~10 mg/dL), which may offset any benefit. For exercise, a 2024 meta-analysis (17 trials) found a small significant gain in maximal strength, concentrated in the lower body (ES ~0.49), with no effect on upper-body or power measures. Body-composition results conflict outright: one meta-analysis found modest body-fat loss, another found none. A 12-month NASH trial improved liver steatosis on imaging but not fibrosis. Overall: a real but narrow biomarker and strength effect, no hard outcomes.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Lowers plasma homocysteineTwo meta-analyses consistently show ~12% / ~1.2-1.3 umol/L reduction at 4-6 g/day; surrogate marker, no hard outcomes. | Strong | ↑ benefit · moderate | 2 |
| Raises total/LDL cholesterolMeta-analysis and RCT show total/LDL rise (~14/~10 mg/dL), potentially offsetting any homocysteine benefit. | Moderate | ⚠ risk · small | 2 |
| Increases lower-body maximal strength17-trial meta-analysis found small strength gain (ES 0.47) confined to lower body; no effect on upper body or power. | Moderate | ↑ benefit · small | 1 |
| Reduces body fatOne meta-analysis found fat loss (-2.5 kg), another found no effect; results conflict outright. | Mixed | ↔ mixed · small | 2 |
| Improves hepatic steatosis in NASH12-month RCT improved steatosis on imaging but not inflammation or fibrosis. | Preliminary | ↑ benefit · small | 1 |